Location History:
- Seocho-gu, KR (2013)
- Seoul, KR (2011 - 2016)
Company Filing History:
5 out of 1,245 
1 out of 321 
Years Active: 2011-2016
Title: Je-Ho Lee: Innovator in Cancer Research
Introduction
Je-Ho Lee, an accomplished inventor based in Seoul, South Korea, has made significant contributions to the field of cancer research, securing a total of five patents. His innovative work focuses primarily on targeting pathways that inhibit tumor growth and metastasis, showcasing his dedication to medical advancements.
Latest Patents
Among his recent inventions, Je-Ho Lee developed a groundbreaking agent that inhibits angiogenesis and metastasis by targeting the mTOR (mammalian target of rapamycin) signaling pathway. This invention highlights the novel function of the Msx1 protein, which plays a crucial role in suppressing tumor angiogenesis necessary for the growth and invasion of solid tumors. By interacting directly with mTOR, Msx1 effectively inhibits angiogenesis, offering a new avenue for cancer treatment. Another noteworthy patent involves TNF-α antagonists containing IGFBP5. This invention relates to a polynucleotide encoding the protein and the development of methods for screening therapeutic agents to combat diseases related to TNF-α overexpression.
Career Highlights
Je-Ho Lee's career is marked by significant roles at notable research institutions. He has contributed to the Sungkyunkwan University Foundation for Corporate Collaboration and the Korea Research Institute of Bioscience and Biotechnology. His work emphasizes the integration of research and application, aiming to bring innovative solutions to practical medical challenges.
Collaborations
Throughout his career, Je-Ho Lee has collaborated with esteemed colleagues such as Kyoungsook Park and Young Woo Park. These partnerships reflect his commitment to teamwork and the collective pursuit of scientific breakthroughs in cancer research.
Conclusion
In conclusion, Je-Ho Lee's contributions to the field of oncology through his innovative patents demonstrate a profound understanding of cancer biology and potential therapies. His work has the potential to revolutionize treatment options for patients, emphasizing the critical role of innovations in the healthcare sector.